FARNUM RHONDA (SVP, Comm & Medical Affairs) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2026ACC: 0001898490-26-000006
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
+18.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
18.75K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+18.75K
Price / share
—
Trade value
—
% of position
8.1%
4/1/2026
232.70K→251.45K
Total
Net shares
+18.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/1/2026 | A · Award | +18.75K | — | — | 8.1% | 232.70K | 251.45K |
| Total | +18.75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported